CTI BioPharma to Present at the JMP Securities Life Sciences Conference on Wednesday, June 16

Rhea-AI Summary

CTI BioPharma Corp. (NASDAQ: CTIC) is set to present a corporate overview at the JMP Securities Life Sciences Conference on June 16, 2021, at 2:30 p.m. ET. The virtual conference will feature a live webcast of the presentation, which can be accessed via CTI BioPharma's website. The company, based in Seattle, specializes in developing targeted therapies for blood-related cancers, focusing on treatments like pacritinib for myelofibrosis and severe COVID-19 disease.

SEATTLE, June 9, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the JMP Securities Life Sciences Conference at 2:30 p.m. ET. The conference will be held in a virtual meeting format.

Presentation details:

Event: JMP Securities Life Sciences Conference
Date: Wednesday, June 16, 2021
Time: 2:30 p.m. ET

The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.

About CTI BioPharma Corp.
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our product candidate currently in active late-stage development, for the treatment of adult patients with myelofibrosis, and in response to the COVID pandemic, severe COVID-19 disease. We are headquartered in Seattle, Washington.

CTI BioPharma Investor Contacts:

Argot Partners

+212-600-1902

cti@argotpartners.com

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-jmp-securities-life-sciences-conference-on-wednesday-june-16-301308699.html

SOURCE CTI BioPharma Corp.

FAQ

When will CTI BioPharma present at the JMP Securities Life Sciences Conference?

CTI BioPharma will present on June 16, 2021, at 2:30 p.m. ET.

Where can I watch CTI BioPharma's presentation?

The presentation will be webcast live and available for replay on CTI BioPharma's website.

What is the focus of CTI BioPharma's research?

CTI BioPharma focuses on developing targeted therapies for blood-related cancers.

What product candidate is CTI BioPharma currently developing?

CTI BioPharma is developing pacritinib for the treatment of myelofibrosis and severe COVID-19.

Where is CTI BioPharma headquartered?

CTI BioPharma is headquartered in Seattle, Washington.